Lanean...
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
Mesenchymal epithelial transition factor receptor (Met) is a receptor tyrosine kinase that plays a critical role in promoting cancer cell malignant progression. Met is activated by its ligand hepatocyte growth factor (HGF). HGF-dependent Met activation plays an important role in stimulating epitheli...
Gorde:
| Argitaratua izan da: | Clin Transl Med |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883993/ https://ncbi.nlm.nih.gov/pubmed/26932375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-014-0030-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|